An intervention to decrease catheter-related bloodstream infections in the ICU
Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel, Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel
Abstract
Background: Catheter-related bloodstream infections occurring in the intensive care unit (ICU) are common, costly, and potentially lethal.
Methods: We conducted a collaborative cohort study predominantly in ICUs in Michigan. An evidence-based intervention was used to reduce the incidence of catheter-related bloodstream infections. Multilevel Poisson regression modeling was used to compare infection rates before, during, and up to 18 months after implementation of the study intervention. Rates of infection per 1000 catheter-days were measured at 3-month intervals, according to the guidelines of the National Nosocomial Infections Surveillance System.
Results: A total of 108 ICUs agreed to participate in the study, and 103 reported data. The analysis included 1981 ICU-months of data and 375,757 catheter-days. The median rate of catheter-related bloodstream infection per 1000 catheter-days decreased from 2.7 infections at baseline to 0 at 3 months after implementation of the study intervention (P< or =0.002), and the mean rate per 1000 catheter-days decreased from 7.7 at baseline to 1.4 at 16 to 18 months of follow-up (P<0.002). The regression model showed a significant decrease in infection rates from baseline, with incidence-rate ratios continuously decreasing from 0.62 (95% confidence interval [CI], 0.47 to 0.81) at 0 to 3 months after implementation of the intervention to 0.34 (95% CI, 0.23 to 0.50) at 16 to 18 months.
Conclusions: An evidence-based intervention resulted in a large and sustained reduction (up to 66%) in rates of catheter-related bloodstream infection that was maintained throughout the 18-month study period.
Copyright 2006 Massachusetts Medical Society.
Source: PubMed
Prochains essais cliniques
-
Kanglin Biotechnology (Hangzhou) Co., Ltd.Pas encore de recrutementMaladie de Parkinson (MP) | Advanced Primary PDChine
-
Carilion ClinicRecrutementHématome sous-dural chronique | RécurrentÉtats-Unis
-
Mahidol UniversityPas encore de recrutementCancer du sein | Carcinome canalaire in situ
-
Biosensors Europe SAPas encore de recrutementNSTEMI | Angine instable (AU) | Poitrine (stable)Royaume-Uni
-
CooperVision International Limited (CVIL)Pas encore de recrutement
-
Shanghai Yueyang Integrated Medicine HospitalRecrutementSarcopénie chez les personnes âgéesChine
-
University of Management and Technology LahorePas encore de recrutementFarward Head PosturePakistan
-
China National Center for Cardiovascular DiseasesPas encore de recrutementBallon enrobé de médicament | Échographie intravasculaire | De Novo Large Coronary VesselChine
-
Korea University Anam HospitalPas encore de recrutementFA - Fibrillation auriculaireCorée du Sud
-
Jijun WangRecrutement
-
DiproBio (Shanghai) Co., Ltd.Pas encore de recrutementSanté mentale | Stress psychologiqueChine
-
Emory UniversityPas encore de recrutementLié à la grossesse | Hypertensive Disorder of Pregnancy (HDP)États-Unis